Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 2
1989 3
1990 2
1991 2
1992 3
1993 4
1994 8
1995 1
1996 1
1997 5
1998 2
1999 10
2000 4
2001 7
2002 6
2003 8
2004 7
2005 2
2006 11
2007 7
2008 9
2009 8
2010 7
2011 13
2012 10
2013 12
2014 11
2015 19
2016 6
2017 9
2018 13
2019 12
2020 7
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Libman I, Bingley PJ, Becker D, Buckner JH, DiMeglio LA, Gitelman SE, Greenbaum C, Haller MJ, Ismail HM, Krischer J, Moore WV, Moran A, Muir AB, Raman V, Steck AK, Toledo FGS, Wentworth J, Wherrett D, White P, You L, Herold KC; Type 1 Diabetes TrialNet Study Group. Libman I, et al. Among authors: bingley pj. Diabetes Care. 2023 Nov 1;46(11):2035-2043. doi: 10.2337/dc23-1096. Diabetes Care. 2023. PMID: 37708415
Prevention of type 1 diabetes.
Thrower SL, Bingley PJ. Thrower SL, et al. Among authors: bingley pj. Br Med Bull. 2011;99:73-88. doi: 10.1093/bmb/ldr020. Epub 2011 Jul 2. Br Med Bull. 2011. PMID: 21725084 Review.
Can we really predict IDDM?
Bingley PJ, Bonifacio E, Gale EA. Bingley PJ, et al. Diabetes. 1993 Feb;42(2):213-20. doi: 10.2337/diab.42.2.213. Diabetes. 1993. PMID: 8425658 Review.
Antiphospholipid antibody syndrome: a review.
Bingley PJ, Hoffbrand BI. Bingley PJ, et al. J R Soc Med. 1987 Jul;80(7):445-8. doi: 10.1177/014107688708000716. J R Soc Med. 1987. PMID: 3116239 Free PMC article. Review. No abstract available.
Clinical applications of diabetes antibody testing.
Bingley PJ. Bingley PJ. J Clin Endocrinol Metab. 2010 Jan;95(1):25-33. doi: 10.1210/jc.2009-1365. Epub 2009 Oct 29. J Clin Endocrinol Metab. 2010. PMID: 19875480 Review.
Safety of high-dose nicotinamide: a review.
Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial Group. Knip M, et al. Among authors: bingley pj. Diabetologia. 2000 Nov;43(11):1337-45. doi: 10.1007/s001250051536. Diabetologia. 2000. PMID: 11126400 Review.
Strategies to prevent type 1 diabetes.
Thrower SL, Bingley PJ. Thrower SL, et al. Among authors: bingley pj. Diabetes Obes Metab. 2009 Oct;11(10):931-8. doi: 10.1111/j.1463-1326.2009.01064.x. Epub 2009 May 19. Diabetes Obes Metab. 2009. PMID: 19476469 Review.
216 results